Theory Paper IIIDrNB Cardiology – Theory Notes
AORTIC DISSECTION CLASSIFICATION; ADVANCES IN MANAGEMENT
IINTRODUCTION AND PATHOPHYSIOLOGY
- Definition: A catastrophic cardiovascular emergency characterized by a tear in the aortic intima that allows pulsatile blood to track into the media, creating a true lumen and a false lumen separated by an intimal flap.
- The Hemodynamic Driver: Propagation of the dissection tear is directly driven by dP/dt (the rate of rise of left ventricular systolic pressure / shear stress) and absolute systolic blood pressure.
IICLASSIFICATION SYSTEMS AND RISK STRATIFICATION
- Stanford Classification (Functionally Guides Management):
- Type A: Involves the Ascending Aorta, regardless of the anatomical site of the primary intimal tear.
- Type B: Does not involve the Ascending Aorta (originates distal to the left subclavian artery).
- DeBakey Classification (Anatomical Origin and Extent):
- Type I: Originates in the ascending aorta and propagates to the aortic arch and descending aorta.
- Type II: Confined strictly to the ascending aorta.
- Type IIIa: Originates in the descending aorta and is confined strictly to the thoracic aorta above the diaphragm.
- Type IIIb: Originates in the descending aorta and extends below the diaphragm into the abdominal aorta.
- Modern ESC/AHA Classification Addition:
- Non-A Non-B Dissection: Involves the aortic arch (either by retrograde extension from the descending aorta or an arch entry tear) while strictly sparing the ascending aorta; managed similarly to complicated Type B dissection or via hybrid arch repair.
- Type B Clinical Risk Stratification:
- Uncomplicated Type B: Pain resolves, blood pressure is controlled, and there is no evidence of rupture or end-organ ischemia.
- High-Risk Uncomplicated Type B: Uncomplicated presentation but with high-risk anatomical features on CTA—such as initial false lumen diameter greater than 22 mm, primary entry tear greater than 10 mm, or partial false lumen thrombosis.
- Complicated Type B: Characterized by refractory pain, rapid aortic expansion (greater than 5 mm), impending/contained rupture, or Malperfusion Syndrome (visceral/mesenteric, renal, spinal cord, or lower-extremity ischemia).
IIIDIAGNOSTIC ALGORITHM
- Biochemical Markers: D-dimer is highly sensitive; a level less than 500 ng/mL helps rule out acute aortic dissection in patients with low-to-intermediate pre-test probability (Class IIa).
- Imaging Modalities:
- CT Angiography (CTA) of the Entire Aorta (Chest, Abdomen, Pelvis): The Class I gold standard for rapid diagnosis, tear classification, branch vessel assessment, and pre-procedural planning.
- Transesophageal Echocardiography (TEE): Reserved strictly for hemodynamically unstable patients in the emergency room or operating theater.
- Magnetic Resonance Angiography (MRA): Preferred for chronic long-term serial surveillance to minimize cumulative radiation and iodinated contrast exposure.
IVACUTE MEDICAL AND DEFINITIVE MANAGEMENT STRATEGIES
AAcute Medical Stabilization (Anti-Impulse Therapy — Class I)
- Hemodynamic Targets: Rapidly reduce Heart Rate to less than 60 bpm and Systolic Blood Pressure to 100 to 120 mmHg.
- Step 1 — Intravenous Beta-Blockade (First-Line): Administer Esmolol or Labetalol intravenously to simultaneously lower heart rate and left ventricular dP/dt (shear stress).
- Step 2 — Intravenous Vasodilators (Second-Line Only): If systolic blood pressure remains elevated after adequate beta-blockade is achieved, add Intravenous Sodium Nitroprusside or Nicardipine.
- Critical Clinical Rule: Never administer a pure vasodilator (such as Nitroprusside or Hydralazine) prior to beta-blockade, as it triggers reflex sympathetic tachycardia, markedly increasing dP/dt and propagating the dissection flap.
BDefinitive Surgical and Endovascular Management
| Dissection Category | Guideline Class | Definitive Management Strategy |
|---|---|---|
| Stanford Type A (DeBakey I & II) | Class I, LOE B | Emergency Open Surgical Repair: Ascending aortic replacement, resection of primary tear, Right Axillary Artery Cannulation (antegrade cerebral perfusion), Valve-Sparing Root Replacement (David) or Bentall, and Frozen Elephant Trunk (FET) for arch/descending extension |
| Complicated Stanford Type B (Malperfusion / Rupture) | Class I, LOE B | Emergency TEVAR (Thoracic Endovascular Aortic Repair) to cover the primary entry tear, expand the true lumen, and restore branch perfusion |
| High-Risk Uncomplicated Type B (False lumen >22 mm, Tear >10 mm) | Class IIa | Pre-emptive / Subacute TEVAR plus optimal medical therapy to induce false lumen thrombosis and prevent late aneurysmal degeneration (INSTEAD-XL & ADSORB Trials) |
| Low-Risk Uncomplicated Type B | Class I | Optimal Medical Therapy (OMT) with strict anti-impulse BP control and serial CTA/MRA surveillance |
VLONG-TERM MANAGEMENT AND SURVEILLANCE
- Lifelong Blood Pressure Target: Maintain blood pressure less than 130/80 mmHg (ESC 2024; SBP below 120 mmHg in the acute phase) to minimize chronic wall stress.
- Disease-Modifying Pharmacotherapy: Lifelong Beta-blockers combined with Angiotensin Receptor Blockers (Losartan or Irbesartan), which inhibit Transforming Growth Factor-beta (TGF-beta) signaling in the aortic media and may slow secondary aneurysmal expansion (evidence mainly from Marfan syndrome).
- Surveillance Imaging Schedule (Class I): Perform CTA or MRA of the entire aorta at 1 month, 3 months, 6 months, 12 months, and annually thereafter for life (dedicated multidisciplinary Aortic Clinics improve compliance; expansion greater than 5 mm/year triggers re-intervention).
- Lifestyle Restrictions: Strict avoidance of competitive contact sports, isometric exercises, and heavy weightlifting (Class IIa).
VIRECENT ADVANCES AND LANDMARK TRIALS
- Surgical Innovations in Type A Dissection:
- Frozen Elephant Trunk (FET): Single-stage hybrid operation combining open surgical replacement of the ascending aorta and arch with antegrade deployment of a stented endograft trunk into the descending aorta, expanding the true lumen and obliterating the proximal false lumen.
- Valve-Sparing Aortic Root Replacement (VSRR / David Procedure): Re-suspends the native aortic valve inside a synthetic graft in young patients, avoiding lifelong anticoagulation.
- Right Axillary Artery Cannulation: Replaces retrograde femoral cannulation during cardiopulmonary bypass, preventing retrograde atheroembolic stroke.
- Endovascular Innovations in Type B Dissection:
- INSTEAD-XL and ADSORB Trials: Demonstrated that adding TEVAR to medical therapy in uncomplicated Type B dissection promotes false lumen thrombosis and true lumen recovery (ADSORB, 1 year) and improved 5-year aorta-specific survival (INSTEAD-XL).
- The FLIRT Concept (False Lumen Interventions to Promote Remodeling and Thrombosis): Uses techniques such as the “Candy-Plug” occluder or coil embolization inside a persistently perfused distal false lumen to force complete thrombosis.
- Fenestrated and Branched TEVAR (F-TEVAR / B-TEVAR): Custom stent-grafts with fenestrations or side-branches that allow endovascular sealing across the visceral and renal arteries.
- 18F-FDG PET-CT (“The Vulnerable Aorta”): Detects active macrophage-driven inflammation in the false lumen wall, an investigational predictor of rapid expansion.
Key references
- Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 12th Ed., Elsevier, 2022.
- Nienaber CA, et al. (INSTEAD-XL Trial) & Brunkwall J, et al. (ADSORB Trial): Endovascular repair vs. medical therapy in uncomplicated Type B aortic dissection.
- Isselbacher EM, et al.: 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease, Circulation, 2022; Mazzolai L, et al.: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases, European Heart Journal, 2024.
meritmedscript.comDr. Sidhartha Mullapudi
